NuCana (NCNA) up 149% after presenting final data from the Phase 2 NuTide:701 study at ESMO Zentalis (ZNTL) up 40% after the FDA lifted the partial clinical hold on studies of azenosertib Bausch + Lomb (BLCO) up 17% after Financial Times reported Bausch + Lomb is considering a sale as a strategy to disentangle itself from its parent company Nuvalent (NUVL) up 21% after the company provided development updates for zidesamtinib and NVL-655 Ascendis Pharma (ASND) up 18% after announcing topline data from the pivotal double-blind placebo-controlled ApproaCH Trial of TransCon CNP
UP AFTER EARNINGS -
ModivCare (MODV) up 2%
DOWN AFTER EARNINGS -
AstroNova (ALOT) down 2%
LOWER -
iTeos Therapeutics (ITOS) down 13% after reporting follow-up interim data from GALAXIES Lung-201 Upstart (UPST) down 8% after announcing offering of $300M of Convertible Senior Notes due 2029 Apple (AAPL) down 2% after analyst Ming Chi-Kuo noted Apple is seeing less demand for iPhone 16 Pro and iPhone 16 Pro Max than expected
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.